Alphaform AG (AFRMF)

[BiotechValues]

Well, they're in a bit of a restructuring phase now, and are looking to raise about 10 million euros to update plant/equipment, but balance sheet OK with current ratio about 1.5

It's ridiculously cheap here- trading about 1 euro above book value and market cap under 20 million USD. For a 3D printing company that raked in $35 M USD in revenue last year, I don't think that valuation will last as US investors discover it.

So to answer your question- I think it will do quite well.

They may list shares in US as an ADR like Groupe Gorge and Arcam AB, which would be a big mover for the stock- and even if that doesn't happen short term, my guess is the shares will be trading as an unsponsored ADR soon. Maybe as early as next week according to my source.

I'm still keeping quiet on it for the most part- added a few shares this morning.